Skip to main content
. 2021 Jan 8;13(2):214. doi: 10.3390/cancers13020214

Figure 2.

Figure 2

Clinical evolution of immune checkpoint-based therapies in B-cell lymphoma over the last 20 years (according to https://beacon-intelligence.com/checkpoint; data actualised in September 2020).